First New York Securities’s AbbVie ABBV Stock Holding History

First New York Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,999	Closed	-$134K	–	337
2015 Q2	$134K	Buy	+1,999	New	+$131K	0.07%	107

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First New York Securities's ABBV Position: Q3 2015 in Review

First New York Securities sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 1,999 shares — an estimated $134K sold.

First New York Securities first reported a position in ABBV in Q2 2015 and held it in 1 quarter. The position peaked at $134K in Q2 2015. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

First New York Securities reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
First New York Securities sold 1,999 AbbVie shares in Q3 2015, an estimated $134K.
First New York Securities first reported a position in AbbVie in Q2 2015 and held it in 1 quarter.
First New York Securities's AbbVie position peaked at $134K in Q2 2015.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on First New York Securities's 13F filing for Q3 2015, filed 27 Oct 2015.